| Symbol | AIDX |
|---|---|
| Name | 20/20 BIOLABS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Services-Testing Laboratories |
| Address | 9430 KEY WEST AVENUE, ROCKVILLE, MD 20850 |
| Telephone | 2404536339 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
New Form 424B3 - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001213900-26-043009 <b>Size:</b> 2 MB
Read moreNew Form 424B3 - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001213900-26-043007 <b>Size:</b> 3 MB
Read moreNew Form EFFECT - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 9999999995-26-001159 <b>Size:</b> 1 KB
Read moreNew Form EFFECT - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 9999999995-26-001126 <b>Size:</b> 1 KB
Read more20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
Read moreBergman Alan B. 🟢 acquired 100.0K shares (1 derivative) of 20/20 Biolabs, Inc. (AIDX) at $1.88 Transaction Date: Apr 02, 2026 | Filing ID: 040583
Read moreZhou Jiming 🟢 acquired 150.0K shares (1 derivative) of 20/20 Biolabs, Inc. (AIDX) at $1.88 Transaction Date: Apr 02, 2026 | Filing ID: 040581
Read moreNew Form S-1 - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001213900-26-040553 <b>Size:</b> 10 MB
Read moreNew Form POS AM - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001213900-26-040545 <b>Size:</b> 11 MB
Read more20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
Read more